Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Amortization of Goodwill (2022 - 2023)

Historic Amortization of Goodwill for Oncology Institute (TOI) over the last 2 years, with Q1 2023 value amounting to $16.9 million.

  • Oncology Institute's Amortization of Goodwill changed N/A to $16.9 million in Q1 2023 from the same period last year, while for Dec 2023 it was $16.9 million, marking a year-over-year increase of 6961.99%. This contributed to the annual value of $16.9 million for FY2023, which is 6961.99% up from last year.
  • Per Oncology Institute's latest filing, its Amortization of Goodwill stood at $16.9 million for Q1 2023.
  • Oncology Institute's 5-year Amortization of Goodwill high stood at $16.9 million for Q1 2023, and its period low was $9.9 million during Q4 2022.